Following an influential study in Wales, they examined whether eligibility for the live herpes zoster vaccine reduces dementia risk in England using a regression discontinuity design based on the 2013 UK rollout. An analysis of over 6.3 million individuals using Hospital Episode Statistics data confirmed that vaccine eligibility significantly reduced hospital-coded herpes zoster, validating the study design....